Healthcare provider profile · identity verified

Sameer T Sawalha, MD

Allopathic & Osteopathic Physicians|Internal Medicine · DEARBORN, MI · NPI 1730152216

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Sameer T Sawalha, MD received $23.21 in general payments during 2025 across 1 reported records.

GlaxoSmithKline, LLC. accounted for 100.0% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 1 associated product.

A separate comparison found the same explicitly named product in public Medicare Part D data: Trelegy Ellipta.

GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SHINGRIX as an associated drug or biological on 43515 records involving 26794 distinct recipient NPIs. Public Medicare Part D data also shows 24 claims for Shingrix by this doctor in 2024.

GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 122 claims for Trelegy Ellipta by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$23.21

1 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
GlaxoSmithKline, LLC.	Unresolved — no canonical attribution shown	$23.21	100.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$23.21	1

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
TRELEGY ELLIPTA Normalized: trelegy ellipta	Drug	GlaxoSmithKline, LLC.	$23.21	1	2025
Source payment records 2025-08-27 · GlaxoSmithKline, LLC. · $23.21 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
TRELEGY ELLIPTA trelegy ellipta	2025	Trelegy Ellipta	2024	122	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference	2025	SHINGRIX open payments reported associated product	CMS Open Payments — General Payments 43515 supporting records · 26794 recipient NPIs · example record 1190332452	Shingrix · 2024 Exact normalized brand match · 1 Part D row	24	18
GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference	2025	TRELEGY ELLIPTA open payments reported associated product	CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369	Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row	122	21

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Albuterol Sulfate Hfa	Albuterol Sulfate	1200	186
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	1132	143
Amlodipine Besylate	Amlodipine Besylate	816	190
Atorvastatin Calcium	Atorvastatin Calcium	729	160
Acetaminophen-Codeine	Acetaminophen With Codeine	638	81
Ibuprofen	Ibuprofen	555	113
Tizanidine Hcl	Tizanidine Hcl	520	116
Omeprazole	Omeprazole	479	112
Rosuvastatin Calcium	Rosuvastatin Calcium	447	97
Metformin Hcl	Metformin Hcl	385	89
Lisinopril	Lisinopril	358	79
Metoprolol Succinate	Metoprolol Succinate	347	82
Furosemide	Furosemide	330	70
Diclofenac Sodium	Diclofenac Sodium	323	76
Fluticasone Propionate	Fluticasone Propionate	312	58
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	304	69
Prednisone	Prednisone	292	163
Potassium Chloride	Potassium Chloride	289	66
Colchicine	Colchicine	286	73
Pantoprazole Sodium	Pantoprazole Sodium	263	54
Gabapentin	Gabapentin	249	52
Tamsulosin Hcl	Tamsulosin Hcl	245	56
Janumet	Sitagliptin Phos/Metformin Hcl	244	33
Losartan Potassium	Losartan Potassium	237	57
Famotidine	Famotidine	220	45
Trazodone Hcl	Trazodone Hcl	215	52
Simvastatin	Simvastatin	208	43
Carvedilol	Carvedilol	196	43
Levothyroxine Sodium	Levothyroxine Sodium	196	43
Zolpidem Tartrate	Zolpidem Tartrate	193	44
Clopidogrel	Clopidogrel Bisulfate	192	40
Azithromycin	Azithromycin	191	136
Montelukast Sodium	Montelukast Sodium	190	40
Naproxen	Naproxen	179	43
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	178	22
Clonidine Hcl	Clonidine Hcl	177	49
Nifedipine Er	Nifedipine	176	42
Esomeprazole Magnesium	Esomeprazole Magnesium	174	44
Eliquis	Apixaban	173	28
Duloxetine Hcl	Duloxetine Hcl	170	50
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	168	38
Linzess	Linaclotide	165	39
Cephalexin	Cephalexin	163	103
Metoprolol Tartrate	Metoprolol Tartrate	163	37
Jardiance	Empagliflozin	161	30
Meloxicam	Meloxicam	158	39
Ventolin Hfa	Albuterol Sulfate	157	38
Trulicity	Dulaglutide	156	30
Megestrol Acetate	Megestrol Acetate	155	35
Tradjenta	Linagliptin	155	23
Jentadueto	Linagliptin/Metformin Hcl	149	20
Ammonium Lactate	Ammonium Lactate	143	34
Enalapril Maleate	Enalapril Maleate	141	33
Farxiga	Dapagliflozin Propanediol	141	26
Ozempic	Semaglutide	136	17
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	131	31
Chlorthalidone	Chlorthalidone	128	37
Ondansetron Hcl	Ondansetron Hcl	128	29
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	122	21
Alcohol Swabs	Alcohol Antiseptic Pads	119	36
Alcohol Prep Pads	Alcohol Antiseptic Pads	110	28
Pregabalin	Pregabalin	110	23
Promethazine Hcl	Promethazine Hcl	110	63
Hydrocortisone	Hydrocortisone	105	39
Donepezil Hcl	Donepezil Hcl	104	23
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	102	26
Glipizide Er	Glipizide	101	22
Buspirone Hcl	Buspirone Hcl	100	22
Celecoxib	Celecoxib	98	30
Hydrochlorothiazide	Hydrochlorothiazide	96	24
Vitamin D2	Ergocalciferol (Vitamin D2)	93	19
Halobetasol Propionate	Halobetasol Propionate	91	18
Finasteride	Finasteride	90	21
Allopurinol	Allopurinol	87	22
Doxazosin Mesylate	Doxazosin Mesylate	86	20
Isosorbide Mononitrate Er	Isosorbide Mononitrate	86	18
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	85	72
Ropinirole Hcl	Ropinirole Hcl	83	16
Alendronate Sodium	Alendronate Sodium	82	13
Incruse Ellipta	Umeclidinium Bromide	82	11
Novolog Flexpen	Insulin Aspart	82	23
Sertraline Hcl	Sertraline Hcl	82	20
Azelastine Hcl	Azelastine Hcl	81	21
Alprazolam	Alprazolam	78	14
Dicyclomine Hcl	Dicyclomine Hcl	77	18
Januvia	Sitagliptin Phosphate	77	12
Quetiapine Fumarate	Quetiapine Fumarate	76	18
Clobetasol Propionate	Clobetasol Propionate	74	19
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	74	16
Fluconazole	Fluconazole	73	39
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	73	21
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	68	21
Ketoconazole	Ketoconazole	65	26
Symbicort	Budesonide/Formoterol Fumarate	65	15
Ciprofloxacin Hcl	Ciprofloxacin Hcl	64	41
Mupirocin	Mupirocin	63	20
Naproxen Sodium	Naproxen Sodium	63	13
Comfort Ez Pen Needle	Pen Needle, Diabetic	62	21
Hydralazine Hcl	Hydralazine Hcl	62	17
Vascepa	Icosapent Ethyl	61	15
Xarelto	Rivaroxaban	61	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	60	14
Icosapent Ethyl	Icosapent Ethyl	59	24
Breo Ellipta	Fluticasone/Vilanterol	58	14
Mometasone Furoate	Mometasone Furoate	58	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	57	14
Levetiracetam	Levetiracetam	56	17
Spironolactone	Spironolactone	56	13
Mirtazapine	Mirtazapine	55	13
Pravastatin Sodium	Pravastatin Sodium	53	12
Tramadol Hcl	Tramadol Hcl	52	21
Fenofibrate	Fenofibrate Nanocrystallized	51	suppressed
Ibu	Ibuprofen	48	11
Sucralfate	Sucralfate	48	14
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	47	13
Oxybutynin Chloride Er	Oxybutynin Chloride	47	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	46	15
Verapamil Er	Verapamil Hcl	46	11
Amitriptyline Hcl	Amitriptyline Hcl	45	suppressed
Metronidazole	Metronidazole	45	25
Oxybutynin Chloride	Oxybutynin Chloride	45	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	44	18
Cyproheptadine Hcl	Cyproheptadine Hcl	44	12
Fenofibrate	Fenofibrate	44	suppressed
Latanoprost	Latanoprost	44	13
Lidocaine-Prilocaine	Lidocaine/Prilocaine	44	suppressed
Procto-Med Hc	Hydrocortisone	44	12
Triamcinolone Acetonide	Triamcinolone Acetonide	43	13
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	43	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	42	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	42	16
Solifenacin Succinate	Solifenacin Succinate	42	18
Entresto	Sacubitril/Valsartan	41	suppressed
Ezetimibe	Ezetimibe	41	suppressed
Gemfibrozil	Gemfibrozil	41	suppressed
Meclizine Hcl	Meclizine Hcl	41	16
Spiriva Handihaler	Tiotropium Bromide	41	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	38	suppressed
Nitroglycerin	Nitroglycerin	38	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	37	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	37	16
Atenolol	Atenolol	35	suppressed
Brilinta	Ticagrelor	35	suppressed
Lidocaine	Lidocaine	35	12
Methylprednisolone	Methylprednisolone	35	21
Glimepiride	Glimepiride	34	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	34	15
Amoxicillin	Amoxicillin	33	28
Fesoterodine Fumarate Er	Fesoterodine Fumarate	33	11
Rizatriptan	Rizatriptan Benzoate	33	11
Chlorhexidine Gluconate	Chlorhexidine Gluconate	32	suppressed
Clonidine	Clonidine	31	13
Glipizide	Glipizide	31	suppressed
Loperamide	Loperamide Hcl	31	19
Memantine Hcl	Memantine Hcl	31	suppressed
Varenicline Tartrate	Varenicline Tartrate	31	11
Acarbose	Acarbose	29	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	29	suppressed
Lovastatin	Lovastatin	28	suppressed
Methocarbamol	Methocarbamol	28	12
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	27	suppressed
Calcitriol	Calcitriol	27	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Lidocaine Hcl Viscous	Lidocaine Hcl	27	suppressed
Dapagliflozin	Dapagliflozin Propanediol	25	17
Ibandronate Sodium	Ibandronate Sodium	25	suppressed
Nystatin	Nystatin	25	15
Amiodarone Hcl	Amiodarone Hcl	24	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	24	18
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	23	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	23	suppressed
Baclofen	Baclofen	22	suppressed
Bupropion Xl	Bupropion Hcl	22	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	22	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	19	suppressed
Aripiprazole	Aripiprazole	19	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Admelog Solostar	Insulin Lispro	18	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	18	suppressed
Ceftriaxone	Ceftriaxone Sodium	18	14
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	18	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	18	suppressed
Lactulose	Lactulose	18	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	18	suppressed
Cilostazol	Cilostazol	17	suppressed
Divalproex Sodium Er	Divalproex Sodium	17	suppressed
Theophylline Er	Theophylline Anhydrous	17	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	16	suppressed
Glyburide-Metformin Hcl	Glyburide/Metformin Hcl	16	suppressed
Methotrexate	Methotrexate Sodium	16	suppressed
Terbinafine Hcl	Terbinafine Hcl	16	suppressed
Zenpep	Lipase/Protease/Amylase	16	suppressed
Acyclovir	Acyclovir	15	suppressed
Ciprofloxacin-Dexamethasone	Ciprofloxacin Hcl/Dexameth	15	suppressed
Jantoven	Warfarin Sodium	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	15	suppressed
Glipizide Xl	Glipizide	14	suppressed
Humalog	Insulin Lispro	14	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Diclofenac Sodium Er	Diclofenac Sodium	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	suppressed
Etodolac Er	Etodolac	13	suppressed
Kerendia	Finerenone	13	suppressed
Levofloxacin	Levofloxacin	13	13
Phenytoin Sodium Extended	Phenytoin Sodium Extended	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	12	suppressed
Hydrocortisone Valerate	Hydrocortisone Valerate	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Metolazone	Metolazone	12	suppressed
Movantik	Naloxegol Oxalate	12	suppressed
Mupirocin	Mupirocin Calcium	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	12	suppressed
Tobramycin-Dexamethasone	Tobramycin/Dexamethasone	12	12
Valsartan	Valsartan	12	suppressed
Vilazodone Hcl	Vilazodone Hcl	12	suppressed
Breyna	Budesonide/Formoterol Fumarate	11	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	11	suppressed
Clindamycin Hcl	Clindamycin Hcl	11	suppressed
Comfort Ez Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	11	suppressed
Erythromycin-Benzoyl Peroxide	Erythromycin/Benzoyl Peroxide	11	suppressed
Fluocinolone Acetonide	Fluocinolone Acetonide	11	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	11	suppressed
Selenium Sulfide	Selenium Sulfide	11	suppressed
Tacrolimus	Tacrolimus	11	suppressed
Tiagabine Hcl	Tiagabine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$23.21 · 1 records	GlaxoSmithKline, LLC.	TRELEGY ELLIPTA	2	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Trelegy Ellipta play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with GlaxoSmithKline, LLC.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error